Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics

[1]  P. Ranjekar,et al.  Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients , 2003, Psychiatry Research.

[2]  X. Zhang,et al.  Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements , 2003, Schizophrenia Research.

[3]  Matcheri Keshavan,et al.  Reduced plasma antioxidants in first-episode patients with schizophrenia , 2003, Schizophrenia Research.

[4]  P. Ranjekar,et al.  Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia , 2003, Schizophrenia Research.

[5]  X. Zhang,et al.  The Effect of Risperidone Treatment on Superoxide Dismutase in Schizophrenia , 2003, Journal of clinical psychopharmacology.

[6]  S. Mahadik,et al.  Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications. , 2003, The Psychiatric clinics of North America.

[7]  X. Zhang,et al.  Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms , 2003, Psychiatry Research.

[8]  V. Parikh,et al.  Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics , 2002, Schizophrenia Research.

[9]  Ömer Akyol,et al.  The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[10]  X. Zhang,et al.  A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. , 2001, The Journal of clinical psychiatry.

[11]  X. Zhang,et al.  The Effect of Extract of Ginkgo Biloba Added to Haloperidol on Superoxide Dismutase in Inpatients With Chronic Schizophrenia , 2001, Journal of clinical psychopharmacology.

[12]  Jeffrey K. Yao,et al.  Abnormal age-related changes of plasma antioxidant proteins in schizophrenia , 2000, Psychiatry Research.

[13]  W. Fenton,et al.  Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia , 2000, Biological Psychiatry.

[14]  Jeffrey K. Yao,et al.  Human plasma glutathione peroxidase and symptom severity in schizophrenia , 1999, Biological Psychiatry.

[15]  J. Chiou,et al.  Elevated lipid peroxidation and disturbed antioxidant enzyme activities in plasma and erythrocytes of patients with uterine cervicitis and myoma. , 1999, Clinical biochemistry.

[16]  J. Coyle,et al.  Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. , 1998, The American journal of psychiatry.

[17]  D. Kammen,et al.  Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. , 1998, Journal of psychiatric research.

[18]  S. Mukherjee,et al.  Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis , 1998, Biological Psychiatry.

[19]  R. Reddy,et al.  Free radical pathology in schizophrenia: a review. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.

[20]  S. Mukherjee,et al.  Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.

[21]  S. Mukherjee,et al.  Impaired antioxidant defense at the onset of psychosis , 1996, Schizophrenia Research.

[22]  R. McCreadie,et al.  The Nithsdale Schizophrenia Surveys. XIV: Plasma Lipid Peroxide and Serum Vitamin E Levels in Patients with and Without Tardive Dyskinesia, and in Normal Subjects , 1995, British Journal of Psychiatry.

[23]  V. Pearson.  Population Policy and Eugenics in China , 1995, British Journal of Psychiatry.

[24]  M. Keshavan,et al.  Erythrocyte membrane phospholipids in psychotic patients , 1993, Psychiatry Research.

[25]  J. Lohr,et al.  Smoking and schizophrenia , 1992, Schizophrenia Research.

[26]  J. Lohr.  Oxygen radicals and neuropsychiatric illness. Some speculations. , 1991, Archives of general psychiatry.

[27]  D. Horrobin,et al.  Fatty acid levels in the brains of schizophrenics and normal controls , 1991, Biological Psychiatry.

[28]  S. Mukherjee,et al.  Enzymes of the antioxidant defense system in chronic schizophrenic patients , 1991, Biological Psychiatry.

[29]  D. Jeste,et al.  Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia , 1990, Biological Psychiatry.

[30]  A. Kling,et al.  Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: Relation to psychosocial variables , 1990, Psychiatry Research.

[31]  Y. Ōyanagui.  Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. , 1984, Analytical biochemistry.

[32]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[33]  J. Lohr,et al.  Oxidative Mechanisms and Tardive Dyskinesia , 2003, CNS drugs.

[34]  V. Parikh,et al.  Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. , 2003, Journal of psychiatric research.

[35]  D. Horrobin,et al.  A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. , 2002, Journal of psychiatric research.

[36]  Jeffrey K. Yao,et al.  Oxidative Damage and Schizophrenia , 2001, CNS drugs.

[37]  H. Herken,et al.  Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia , 2001, Molecular Psychiatry.

[38]  Brown Ja,et al.  Free radical involvement in neuropsychiatric illnesses. , 1995 .

[39]  K. Yagi.  Lipid peroxides and related radicals in clinical medicine. , 1994, Advances in experimental medicine and biology.

[40]  G. Reynolds,et al.  Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment , 1993, International clinical psychopharmacology.

[41]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[42]  H. Aebi,et al.  Catalase in vitro. , 1984, Methods in enzymology.